Urogen Pharma shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Urogen Pharma
Tip: Access up to 7 years of quarterly data
All positions including Urogen Pharma held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Urogen Pharma by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $943k | 63k | 15.00 |
| 2023-09-30 | $650k | 46k | 14.01 |
| 2023-06-30 | $463k | 45k | 10.35 |
| 2022-03-31 | $372k | 43k | 8.71 |
| 2021-12-31 | $406k | 43k | 9.51 |
| 2021-09-30 | $719k | 43k | 16.84 |
| 2021-06-30 | $619k | 41k | 15.28 |
| 2021-03-31 | $796k | 41k | 19.48 |
| 2020-12-31 | $740k | 41k | 18.03 |
| 2020-09-30 | $772k | 40k | 19.31 |
| 2020-06-30 | $1.1M | 42k | 26.13 |
| 2020-03-31 | $724k | 41k | 17.85 |
| 2019-12-31 | $1.3M | 40k | 33.38 |
| 2019-09-30 | $934k | 39k | 23.84 |
| 2019-06-30 | $1.4M | 39k | 35.94 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management